Skip to content
Disclosery

Royalty Pharma Manager, LLC

Follow

13F filer, CIK 2077508, New York, NY

Royalty Pharma Manager, LLC filed a 13F-NT notice for the quarter ended 2025-12-31 on 2026-04-01.

Filed (acceptance time not in the bulk data set), ingested 13F-NT 0002077508-26-000002

This filer reports no holdings of its own for Q4 2025. It filed a 13F-NT notice, and its holdings are in the report of
    . How notices are handled.

    Part of the filer group Royalty Pharma Sub-Manager, LLC

    How groups are built

    How Q4 2025 was built

    Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

    FilingRoleAmendmentFiledAcceptedIngested
    13F-NT 0002077508-26-000002 notice2026-04-01acceptance time not in the bulk data set